Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

View:
Post by Kingofstockst on Apr 05, 2021 11:42pm

I

Warned you clowns about this company... it's a scam I just feel bad for the honest investors not the paid pumpers, tomorrow sell cut you're losses and move on......
Comment by Thanks1 on Apr 06, 2021 5:21am
Salzman always gets paid they will bleed Kly until it dies while advancing R 107 and pass it to someone else same as GVHD. Another great story plays out like the batman series WOW, POW and so on. Lets hope this changes.
Comment by Bigginvestor on Apr 06, 2021 6:45am
no one is a paid pumper here .just watch and see read the NR man .
Comment by indaknownewfie on Apr 07, 2021 5:12pm
https://www.investmentexecutive.com/newspaper_/news-newspaper/anonymous-comments-prove-costly/ You need to read this King 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities